Clinical Trial Update: Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluating isradipine for cognitive enhancement in schizophrenia and schizoaffective disorder; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Isradipine (isradipine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2018-12-05